The use of S100B as a biomarker in subarachnoid hemorrhage: clarity in its promise and limits.
Publication
, Journal Article
Laskowitz, DT; Warner, DS
Published in: Crit Care Med
August 2008
Duke Scholars
Published In
Crit Care Med
DOI
EISSN
1530-0293
Publication Date
August 2008
Volume
36
Issue
8
Start / End Page
2452 / 2453
Location
United States
Related Subject Headings
- Subarachnoid Hemorrhage
- S100 Proteins
- S100 Calcium Binding Protein beta Subunit
- Prognosis
- Nerve Growth Factors
- Humans
- Emergency & Critical Care Medicine
- Biomarkers
- 4205 Nursing
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Laskowitz, D. T., & Warner, D. S. (2008). The use of S100B as a biomarker in subarachnoid hemorrhage: clarity in its promise and limits. Crit Care Med, 36(8), 2452–2453. https://doi.org/10.1097/CCM.0b013e3181810457
Laskowitz, Daniel T., and David S. Warner. “The use of S100B as a biomarker in subarachnoid hemorrhage: clarity in its promise and limits.” Crit Care Med 36, no. 8 (August 2008): 2452–53. https://doi.org/10.1097/CCM.0b013e3181810457.
Laskowitz DT, Warner DS. The use of S100B as a biomarker in subarachnoid hemorrhage: clarity in its promise and limits. Crit Care Med. 2008 Aug;36(8):2452–3.
Laskowitz, Daniel T., and David S. Warner. “The use of S100B as a biomarker in subarachnoid hemorrhage: clarity in its promise and limits.” Crit Care Med, vol. 36, no. 8, Aug. 2008, pp. 2452–53. Pubmed, doi:10.1097/CCM.0b013e3181810457.
Laskowitz DT, Warner DS. The use of S100B as a biomarker in subarachnoid hemorrhage: clarity in its promise and limits. Crit Care Med. 2008 Aug;36(8):2452–2453.
Published In
Crit Care Med
DOI
EISSN
1530-0293
Publication Date
August 2008
Volume
36
Issue
8
Start / End Page
2452 / 2453
Location
United States
Related Subject Headings
- Subarachnoid Hemorrhage
- S100 Proteins
- S100 Calcium Binding Protein beta Subunit
- Prognosis
- Nerve Growth Factors
- Humans
- Emergency & Critical Care Medicine
- Biomarkers
- 4205 Nursing
- 3202 Clinical sciences